Mapping of the Wnt/β-Catenin/TCF response elements in the human versican promoter

Methods in Molecular Biology

Volumn 836, Issue , 2012, Pages 35-52

  Rahmani, Maziar ^a   Carthy, Jon M ^a   McManus, Bruce M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

catenin; EMSA; Luciferase; Promoter activity; TCF LEF recognition site; Versican; Wnt pathway

Indexed keywords

BETA CATENIN; T CELL FACTOR PROTEIN; VCAN PROTEIN, HUMAN; VERSICAN; WNT PROTEIN;

DNA RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION;

BETA CATENIN; HUMANS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VERSICANS; WNT PROTEINS;

EID: 84856334082     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-498-8_3     Document Type: Review

References (23)

1. Kinsella, M.G.; Bressler, S.L.; Wight, T.N. (2004) The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that Influence cellular phenotype. Crit Rev Eukaryot Gene Expr. 14 , 203-234. (Pubitemid 38931846)
2. Rahmani, M.; Wong, B.W.; Ang, L.; Cheung, C.C.; Carthy, J.M.; Walinski, H.; McManus, B.M. (2006) Versican: signaling to transcriptional control pathways. Can J Physiol Pharmacol. 84 , 77-92. (Pubitemid 44011953)
3. Wight, T.N. and Merrilees, M.J. (2004) Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res. 94 , 1158-1167. (Pubitemid 38656402)
4. Rahmani, M.; McDonald, P.C.; Wong, B.W.; McManus, B.M. (2004) Transplant vascular disease: Role of lipids and proteoglycans. Can J Cardiol. 20: 58B-65B.
5. Wight, T.N. (2008) Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front Biosci. 13 , 4933-4937. (Pubitemid 351599647)
6. Ricciardelli, C.; Sakko, A.J.; Ween, M.P.; Russell, D.L.; Horsfall, D.J. (2009) The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev. 28 , 233-245.
7. Morgenstern, D.A.; Asher, R.A.; Fawcett, J.W. (2002) Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res. 137 , 313-332. (Pubitemid 35460952)
8. Zimmermann, D.R. and Dours-Zimmermann, M.T. (2008) Extracellular matrix of the central nervous system: from neglect to challenge. Histochem Cell Biol. 130 , 635-653.
9. Wu, Y.J.; Lapierre, D.; Wu, J.; Yee, A.J.; Yang, B.B. (2005) The interaction of versican with its binding partners. Cell Res. 15 , 483-494. (Pubitemid 41653919)
10. Cowin, P. (1994) Unraveling the cytoplasmic interactions of the cadherin superfamily. Proc Natl Acad Sci USA 91 , 10759-10761. (Pubitemid 24349563)
11. Korinek, V.; Barker, N.; Morin, P.J.; van Wichen, D.; de Weger, R.; Kinzler, K.W.; et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC colon carcinoma. Science 275, 1784-1787. (Pubitemid 27136714)
12. Rahmani, M.; Read, J.T.; Carthy, J.M.; McDonald, P.C.; Wong, B.W.; Esfandiarei, M.; et al. (2005) Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells. J Biol Chem. 280 , 13019-13028.
13. Read, J.T.; Rahmani, M.; Boroomand, S.; Allahverdian, S.; McManus, B.M.; Rennie, P.S. (2007) Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter. J Biol Chem. 282 , 31954-31963. (Pubitemid 350106418)
14. Farb, A.; Kolodgie, F.D.; Hwang, J.Y.; Burke, A.P, Tefera, K.; Weber, D.K.; et al. (2004) Extracellular matrix changes in stented human coronary arteries. Circulation 110 , 940-947. (Pubitemid 39128619)
15. Lin, H.; Ignatescu, M.; Wilson, J.E.; Roberts, C.R.; Horley, K.J.; Winters, G.L.; et al. (1996) Prominence of apolipoproteins B, (a), and E in the intimae of coronary arteries in transplanted human hearts: geographic relationship to vessel wall proteoglycans. J Heart Lung Transplant. 15 , 1223-1232. (Pubitemid 26428398)
16. Lin, H.; Wilson, J.E.; Roberts, C.R.; Horley, K.J.; Winters, G.L.; Costanzo, M.R.; McManus, B.M. (1996) Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis. J Heart Lung Transplant. 15 , 1233-1247. (Pubitemid 26428399)
17. Lin, H.; Kanda, T.; Hoshino, Y.; Takase, S.; Kobayashi, I.; Nagai, R.; McManus, B.M. (1998) Versican, biglycan and decorin protein expression patterns in coronary arteries: Analysis of primary and restenotic lesions. Cardiovasc Pathol. 7 , 31-37. (Pubitemid 28037491)
18. Williams, K.J. and Tabas, I. (1995) The responseto-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 15 , 551-561.
19. Williams, K.J. (2001) Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherogenesis. Curr Opin Lipidol. 12 , 477-487. (Pubitemid 32980295)
20. Naso, M.F.; Zimmermann, D.R.; Iozzo, R.V. (1994) Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem; 269 , 32999-33008.
21. Yeung, L.H.; Read, J.T.; Sorenson, P.; Nelson, C.C.; Gleave, M.; Jia, W.; Rennie, P.S. (2003) Identification and characterization of a prostate-specific androgen independentprotein binding site in the probasin promoter. Biochem J. 371 , 843-855. (Pubitemid 36578883)
22. Thyberg, J. (1996) Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol. 169 , 183-265.
23. Campbell, J.H. and Campbell, G.R. (1993) Culture techniques and their applications to studies of vascular smooth muscle. Clin Sci (Lond) 85 , 501-513. (Pubitemid 23336533)